1888PressRelease.com
1888 PressRelease Home Sign In Sign Up Contact Us About Us Sitemap

Cornerstonebiopharma.com - Cornerstone Biopharma Company News Section

Cornerstone Biopharma Information
Jonathon Jordan
URL: http://www.cornerstonebiopharma.com
Cornerstone BioPharma, Inc. http://www.cornerstonebiopharma.com, located next to North Carolina’s Research Triangle Park, is an emerging specialty pharmaceutical company that is currently focused on the development and commercialization of niche prescription medications in the respiratory arena. Cornerstone is actively engaged in strategic licensing of additional prescription products through acquisitions, strategic partnerships and new product development.
Cornerstone Biopharma Press Release -

Cornerstonebiopharma.com

20
MAR
Cornerstone BioPharma, Inc. Names George Esgro Vice President Of Sales And Marketing
Specialty pharmaceutical company builds executive team to drive strategic sales and marketing initiatives
20
MAR
Cornerstone BioPharma, Inc. Names George Esgro Vice President Of Sales And Marketing
Specialty pharmaceutical company builds executive team to drive strategic sales and marketing initiatives
06
MAR
Cornerstone Biopharma, Inc. Introduces New Allerx® Dose Pack
Specialty pharmaceutical company releases new product for Allergic Rhinitis
20
JAN
Cornerstone Biopharma, J-med Pharmaceuticals And Sovereign Pharmaceuticals Settle Pending Litigation Concerning U.s. Patent No. 6,270,796 And Allerx™ Dose Pack
Cornerstone BioPharma (“Cornerstone”) of Cary, North Carolina, and J-Med Pharmaceuticals (“J-Med”) of Boston, Massachusetts, today announced that they have settled pending patent litigation with Sovereign Pharmaceuticals, Ltd., (“Sovereign”) of Fort Worth, Texas, in connection with U.S. Patent No. 6,270,796 (“the ‘796 patent”).
09
NOV
Cornerstone Biopharma, Inc. Obtains Exclusive Licensing Rights For Spectracef
Triangle-based specialty pharmaceutical company to serve $1.3 billion per year oral cephalosporin market